Information  X 
Enter a valid email address

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

By BFN News | 09:40 AM | Wednesday 12 August, 2020

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t